Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Narcolepsy01:07

Narcolepsy

208
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
208
Sleep-Wake Cycles01:24

Sleep-Wake Cycles

1.7K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
1.7K
REM Sleep Behavior Disorder01:15

REM Sleep Behavior Disorder

435
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
435
Sleep Apnea01:21

Sleep Apnea

227
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
227
Management of Insomnia01:19

Management of Insomnia

328
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
328
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

333
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
333

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antibodies against influenza A/H1N1pdm2009 and B/Victoria strains but not A/H3N2 are increased in recent onset type 1 narcolepsy versus matched controls.

medRxiv : the preprint server for health sciences·2026
Same author

Content Validity and Psychometric Evaluation of the Idiopathic Hypersomnia Severity Scale (IHSS) in Adults with Idiopathic Hypersomnia.

Nature and science of sleep·2026
Same authorSame journal

Postmortem Evidence of CRH Neuron Reduction in Narcolepsy Without Cataplexy With Borderline Hypocretin-1 Levels.

Journal of sleep research·2026
Same author

Protocol for the DREAMER study: Design and methodological framework of a multicenter trial-ready cohort of individuals with isolated REM sleep without atonia.

PloS one·2026
Same author

Slow-Wave Sleep Fragmentation in Disorders of Arousal and Sleep-Related Hypermotor Epilepsy: A Multicenter Polysomnographic Study.

Neurology·2026
Same author

To diagnose Narcolepsy type 1 after a negative Multiple Sleep Latency Test: the contribution of systematic hypocretin measurement.

Sleep·2026
Same journal

Continuous Positive Airway Pressure Versus Mandibular Advancement Devices Impact on Cardio-Metabolic Outcomes in Patients With Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

Journal of sleep research·2026
Same journal

Strong and Weak Episodic Memories Are Shaped by Multiple Cycles of NREM Spindles and REM Alpha Bursts.

Journal of sleep research·2026
Same journal

A Systematic Review and Meta-Analysis of Biological Sex Differences in Sleep Spindles and Slow Wave Activity in Adults With and Without Insomnia.

Journal of sleep research·2026
Same journal

Thoracoabdominal Asynchrony in Healthy Children.

Journal of sleep research·2026
Same journal

Chronotype and Time of Day Effects in Oddball Task Performance: Behavioural and Cerebral Correlates.

Journal of sleep research·2026
See all related articles

Related Experiment Video

Updated: Sep 21, 2025

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
08:20

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood

Published on: October 2, 2019

12.1K

Narcolepsy.

Lucie Barateau1,2,3, Fabio Pizza4,5, Giuseppe Plazzi5,6

  • 1Sleep-Wake Disorders Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, Montpellier, France.

Journal of Sleep Research
|May 27, 2022
PubMed
Summary
This summary is machine-generated.

Narcolepsy type 1 is diagnosed by low hypocretin-1 levels, linked to autoimmune neuron loss. Narcolepsy type 2 needs more research, but new treatments offer hope for these sleep disorders.

Keywords:
narcolepsy type 1narcolepsy type 2orexin/hypocretinpathophysiologytreatment

More Related Videos

Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

24.2K
Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

9.7K

Related Experiment Videos

Last Updated: Sep 21, 2025

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood
08:20

Measuring Neural Mechanisms Underlying Sleep-Dependent Memory Consolidation During Naps in Early Childhood

Published on: October 2, 2019

12.1K
Polygraphic Recording Procedure for Measuring Sleep in Mice
08:45

Polygraphic Recording Procedure for Measuring Sleep in Mice

Published on: January 25, 2016

24.2K
Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

9.7K

Area of Science:

  • Neurology
  • Sleep Medicine
  • Immunology

Background:

  • Narcolepsy encompasses type 1 (NT1) and type 2 (NT2), distinct disorders affecting sleep regulation.
  • NT1 is characterized by hypocretin deficiency, leading to hallmark symptoms like cataplexy.
  • NT2 is less understood, with a variable presentation and unclear etiology.

Purpose of the Study:

  • To review recent findings on the clinical presentation, diagnosis, pathophysiology, and management of narcolepsy types 1 and 2.
  • To highlight the role of hypocretin-1/orexin-A in NT1 diagnosis and pathogenesis.
  • To discuss current and emerging therapeutic strategies for narcolepsy.

Main Methods:

  • Review of recent scientific literature and clinical findings.
  • Analysis of diagnostic biomarkers, particularly hypocretin-1 levels in cerebrospinal fluid.
  • Examination of the suspected autoimmune mechanisms underlying hypocretin neuron loss.

Main Results:

  • Low cerebrospinal fluid hypocretin-1/orexin-A is a specific biomarker for diagnosing NT1.
  • Autoimmune processes are strongly implicated in the destruction of hypocretin neurons in NT1.
  • NT2 remains poorly defined, lacking reliable biomarkers and a clear understanding of its cause.
  • Current treatments are symptomatic, but novel psychostimulants and hypocretin receptor agonists are emerging.

Conclusions:

  • Hypocretin neuron loss is central to NT1 pathophysiology, with autoimmune destruction being the leading hypothesis.
  • Further research is crucial to elucidate the etiology and identify biomarkers for NT2.
  • Advancements in understanding and treatment, including hypocretin receptor agonists, promise significant improvements for narcolepsy management.